Sewa Surgicals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 16-11-2024
- Paid Up Capital ₹ 6.60 M
as on 16-11-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 73.00 Cr
as on 16-11-2024
- Revenue -52.21%
(FY 2023)
- Profit -1470.65%
(FY 2023)
- Ebitda 9.23%
(FY 2023)
- Net Worth -24.84%
(FY 2023)
- Total Assets -1.99%
(FY 2023)
About Sewa Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 6.60 M.
The company has closed loans amounting to ₹73.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shiv Srivastava, Vishal Rungta, and Pradeep Rungta serve as directors at the Company.
- CIN/LLPIN
U33111UP2007PTC033468
- Company No.
033468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sewa Surgicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Srivastava  | Director | 13-Feb-2024 | Current |
| Vishal Rungta | Director | 18-Jan-2021 | Current |
| Pradeep Rungta | Director | 18-Jan-2021 | Current |
Financial Performance of Sewa Surgicals.
Sewa Surgicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.21% decrease. The company also saw a substantial fall in profitability, with a 1470.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sewa Surgicals?
In 2023, Sewa Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shudh Plus Hygiene Products Private LimitedActive 8 years 6 monthsPradeep Rungta is a mutual person
Charges (Loans)
₹0
₹730.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 73.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jun 2021 | Hdfc Bank Limited | ₹73.00 Cr | Satisfied |
How Many Employees Work at Sewa Surgicals?
Unlock and access historical data on people associated with Sewa Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sewa Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sewa Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
